TY - JOUR AU - Bellmunt, J. AU - Orsola, A. AU - Maldonado, X. AU - Kataja, V. PY - 2010 DA - 2010// TI - Bladder cancer: ESMO practice guidelines for diagnosis, treatment and follow-up JO - Ann Oncol VL - 21 UR - https://doi.org/10.1093/annonc/mdq175 DO - 10.1093/annonc/mdq175 ID - Bellmunt2010 ER - TY - JOUR AU - Clark, P. E. AU - Agarwal, N. AU - Biagioli, M. C. PY - 2013 DA - 2013// TI - Bladder cancer JO - J Natl Compr Cancer Netw VL - 11 UR - https://doi.org/10.6004/jnccn.2013.0059 DO - 10.6004/jnccn.2013.0059 ID - Clark2013 ER - TY - JOUR AU - Bruins, H. M. AU - Skinner, E. C. AU - Dorin, R. P. PY - 2014 DA - 2014// TI - Incidence and location of lymph node metastases in patients undergoing radical cystectomy for clinical non-muscle invasive bladder cancer: results from a prospective lymph node mapping study JO - Urol Oncol VL - 32 UR - https://doi.org/10.1016/j.urolonc.2012.08.015 DO - 10.1016/j.urolonc.2012.08.015 ID - Bruins2014 ER - TY - JOUR AU - Chamberlain, M. C. PY - 2006 DA - 2006// TI - Neoplastic meningitis JO - Neurologist VL - 12 UR - https://doi.org/10.1097/01.nrl.0000219732.33321.cc DO - 10.1097/01.nrl.0000219732.33321.cc ID - Chamberlain2006 ER - TY - JOUR AU - Miettinen, M. AU - Cue, P. A. M. AU - Sarlomo-Rikala, M. PY - 2014 DA - 2014// TI - GATA 3 – a multispecific but potentially useful marker in surgical pathology – a systematic analysis of 2500 epithelial and non-epithelial tumors JO - Am J Surg Pathol VL - 38 UR - https://doi.org/10.1097/PAS.0b013e3182a0218f DO - 10.1097/PAS.0b013e3182a0218f ID - Miettinen2014 ER - TY - JOUR AU - Matthews, P. N. AU - Madden, M. AU - Bidgood, K. A. AU - Fisher, C. PY - 1984 DA - 1984// TI - The clinicopathological features of metastatic superficial papillary bladder cancer JO - J Urol VL - 132 ID - Matthews1984 ER - TY - JOUR AU - Lebret, T. AU - Méjean, A. PY - 2008 DA - 2008// TI - Rare locations of metastases from urothelial carcinoma JO - Prog En Urol VL - 18 UR - https://doi.org/10.1016/S1166-7087(08)74557-3 DO - 10.1016/S1166-7087(08)74557-3 ID - Lebret2008 ER - TY - JOUR AU - Babaian, R. J. AU - Johnson, D. E. AU - Llamas, L. AU - Ayala, A. G. PY - 1980 DA - 1980// TI - Metastases from transitional cell carcinoma of urinary bladder JO - Urology VL - 16 UR - https://doi.org/10.1016/0090-4295(80)90067-9 DO - 10.1016/0090-4295(80)90067-9 ID - Babaian1980 ER - TY - JOUR AU - Jessen, C. AU - Agerbaek, M. AU - Von Der Maase, H. PY - 2009 DA - 2009// TI - Predictive factors for response and prognostic factors for long-term survival in consecutive, single institution patients with locally advanced and/or metastatic transitional cell carcinoma following cisplatin-based chemotherapy JO - Acta Oncol VL - 48 UR - https://doi.org/10.1080/02841860802325932 DO - 10.1080/02841860802325932 ID - Jessen2009 ER - TY - JOUR AU - Uncu, D. AU - Arpaci, F. AU - Beyzadeoglu, M. PY - 2010 DA - 2010// TI - Meningeal carcinomatosis: an extremely rare involvement of urinary bladder carcinoma JO - Tumori VL - 96 ID - Uncu2010 ER - TY - JOUR AU - Leal, T. AU - Chang, J. E. AU - Mehta, M. AU - Robins, H. I. PY - 2011 DA - 2011// TI - Leptomeningeal Metastasis: challenges in diagnosis and treatment JO - Curr Cancer Ther Rev VL - 7 UR - https://doi.org/10.2174/157339411797642597 DO - 10.2174/157339411797642597 ID - Leal2011 ER - TY - JOUR AU - Sternberg, C. N. AU - Yagoda, A. AU - Scher, H. I. PY - 1989 DA - 1989// TI - Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse JO - Cancer VL - 64 UR - https://doi.org/3.0.CO;2-7 DO - 3.0.CO;2-7 ID - Sternberg1989 ER - TY - JOUR AU - Maase, H. AU - Hansen, S. W. AU - Roberts, J. T. PY - 2000 DA - 2000// TI - Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study JO - J Clin Oncol VL - 18 UR - https://doi.org/10.1200/JCO.2000.18.17.3068 DO - 10.1200/JCO.2000.18.17.3068 ID - Maase2000 ER -